ICHOM Patient Centered Outcomes Measure Set for Breast Cancer
1.0.0 - trial-use International flag

This page is part of the ICHOM FHIR Implementation Guide: Breast Cancer (v1.0.0: STU 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: Staging Type for Stage Group ValueSet

Official URL: http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMStageGroupVS Version: 1.0.0
Standards status: Trial-use Maturity Level: 2 Computable Name: TNMStageGroupVS

Copyright/Legal: This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc

Valueset indicating the type of staging, clinical or pathological, of breast cancer.

References

Logical Definition (CLD)

 

Expansion

This value set contains 2 concepts

Expansion based on Loinc v2.74

CodeSystemDisplay
  21908-9http://loinc.orgStage group.clinical Cancer
  21902-2http://loinc.orgStage group.pathology Cancer

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code